I understand how everyone is upset about WSJ hit p
Post# of 148169
Why is the NIH sponsoring a trial with lenzulimab when we all know that leronlimab is the much superior drug to calm the cytokine storm? Does the NIH even know about leronlimab? They must. Why haven't they reached out or why hasn't CYDY reached out to them? I feel like we have enough positive data to be approached by or to approach them, no?